We previously prepared nerve growth factor poly-lactide co-glycolid sustained-release microspheres to treat rat sciatic nerve injury using the small gap sleeve technique.Multiple growth factors play a synergistic role...We previously prepared nerve growth factor poly-lactide co-glycolid sustained-release microspheres to treat rat sciatic nerve injury using the small gap sleeve technique.Multiple growth factors play a synergistic role in promoting the repair of peripheral nerve injury;as a result,in this study,we added basic fibroblast growth factors to the microspheres to further promote nerve regeneration.First,in an in vitro biomimetic microenvironment,we developed and used a drug screening biomimetic microfluidic chip to screen the optimal combination of nerve growth factor/basic fibroblast growth factor to promote the regeneration of Schwann cells.We found that 22.56 ng/mL nerve growth factor combined with 4.29 ng/mL basic fibroblast growth factor exhibited optimal effects on the proliferation of primary rat Schwann cells.The successfully prepared nerve growth factor-basic fibroblast growth factor-poly-lactide-co-glycolid sustained-release microspheres were used to treat rat sciatic nerve transection injury using the small gap sleeve bridge technique.Compared with epithelium sutures and small gap sleeve bridging alone,the small gap sleeve bridging technique combined with drug-free sustained-release microspheres has a stronger effect on rat sciatic nerve transfection injury repair at the structural and functional level.展开更多
Advances in multi-omics datasets and analytical methods have revolutionized cancer research,offering a comprehensive,pan-cancer perspective.Pancancer studies identify shared mechanisms and unique traits across differe...Advances in multi-omics datasets and analytical methods have revolutionized cancer research,offering a comprehensive,pan-cancer perspective.Pancancer studies identify shared mechanisms and unique traits across different cancer types,which are reshaping diagnostic and treatment strategies.However,continued innovation is required to refine these approaches and deepen our understanding of cancer biology and medicine.This review summarized key findings from pan-cancer research and explored their potential to drive future advancements in oncology。展开更多
基金supported by the National Key Research and Development Program of China, No. 2016YFC1101603 (to DYZ)the National Natural Science Foundation of China, Nos. 31640045 (to YHW), 81901251 (to ML)the Natural Science Foundation of Beijing of China, No. 7204323 (to ML)
文摘We previously prepared nerve growth factor poly-lactide co-glycolid sustained-release microspheres to treat rat sciatic nerve injury using the small gap sleeve technique.Multiple growth factors play a synergistic role in promoting the repair of peripheral nerve injury;as a result,in this study,we added basic fibroblast growth factors to the microspheres to further promote nerve regeneration.First,in an in vitro biomimetic microenvironment,we developed and used a drug screening biomimetic microfluidic chip to screen the optimal combination of nerve growth factor/basic fibroblast growth factor to promote the regeneration of Schwann cells.We found that 22.56 ng/mL nerve growth factor combined with 4.29 ng/mL basic fibroblast growth factor exhibited optimal effects on the proliferation of primary rat Schwann cells.The successfully prepared nerve growth factor-basic fibroblast growth factor-poly-lactide-co-glycolid sustained-release microspheres were used to treat rat sciatic nerve transection injury using the small gap sleeve bridge technique.Compared with epithelium sutures and small gap sleeve bridging alone,the small gap sleeve bridging technique combined with drug-free sustained-release microspheres has a stronger effect on rat sciatic nerve transfection injury repair at the structural and functional level.
基金supported by the Self-supporting Program of Guangzhou Laboratory(SRPG22007)the CAS Research Fund(XDB38050200)+1 种基金the National Key Research and Development Program of China(2021YFA0910100)Healthy Zhejiang One Million People Cohort(K-20230085).
文摘Advances in multi-omics datasets and analytical methods have revolutionized cancer research,offering a comprehensive,pan-cancer perspective.Pancancer studies identify shared mechanisms and unique traits across different cancer types,which are reshaping diagnostic and treatment strategies.However,continued innovation is required to refine these approaches and deepen our understanding of cancer biology and medicine.This review summarized key findings from pan-cancer research and explored their potential to drive future advancements in oncology。
